IBDEI0JH ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8763,1,4,0)
 ;;=4^Z80.42
 ;;^UTILITY(U,$J,358.3,8763,2)
 ;;=^5063349
 ;;^UTILITY(U,$J,358.3,8764,0)
 ;;=Z80.43^^39^402^33
 ;;^UTILITY(U,$J,358.3,8764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8764,1,3,0)
 ;;=3^Family Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,8764,1,4,0)
 ;;=4^Z80.43
 ;;^UTILITY(U,$J,358.3,8764,2)
 ;;=^5063350
 ;;^UTILITY(U,$J,358.3,8765,0)
 ;;=Z80.6^^39^402^25
 ;;^UTILITY(U,$J,358.3,8765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8765,1,3,0)
 ;;=3^Family Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,8765,1,4,0)
 ;;=4^Z80.6
 ;;^UTILITY(U,$J,358.3,8765,2)
 ;;=^5063354
 ;;^UTILITY(U,$J,358.3,8766,0)
 ;;=Z80.8^^39^402^30
 ;;^UTILITY(U,$J,358.3,8766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8766,1,3,0)
 ;;=3^Family Hx of Malig Neop of Organs/Systems
 ;;^UTILITY(U,$J,358.3,8766,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,8766,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,8767,0)
 ;;=Z81.8^^39^402^35
 ;;^UTILITY(U,$J,358.3,8767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8767,1,3,0)
 ;;=3^Family Hx of Mental/Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,8767,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,8767,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,8768,0)
 ;;=Z82.3^^39^402^42
 ;;^UTILITY(U,$J,358.3,8768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8768,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,8768,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,8768,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,8769,0)
 ;;=Z82.49^^39^402^24
 ;;^UTILITY(U,$J,358.3,8769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8769,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
 ;;^UTILITY(U,$J,358.3,8769,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,8769,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,8770,0)
 ;;=Z82.5^^39^402^14
 ;;^UTILITY(U,$J,358.3,8770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8770,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,8770,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,8770,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,8771,0)
 ;;=Z82.61^^39^402^13
 ;;^UTILITY(U,$J,358.3,8771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8771,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,8771,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,8771,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,8772,0)
 ;;=Z82.69^^39^402^37
 ;;^UTILITY(U,$J,358.3,8772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8772,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,8772,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,8772,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,8773,0)
 ;;=Z83.3^^39^402^20
 ;;^UTILITY(U,$J,358.3,8773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8773,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,8773,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,8773,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,8774,0)
 ;;=Z83.2^^39^402^16
 ;;^UTILITY(U,$J,358.3,8774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8774,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,8774,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,8774,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,8775,0)
 ;;=Z82.71^^39^402^40
 ;;^UTILITY(U,$J,358.3,8775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8775,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,8775,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,8775,2)
 ;;=^321531
